Ever Source Wealth Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 38 shares of RARE stock, worth $1,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 13
192.31%
Holding current value
$1,402
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$369 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$207 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$154 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$119 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$96.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.59B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...